日本女性健康科技市場前景及投資研究報告-培訓(xùn)課件外文版2024.4

DIGITAL

&

TRENDSWomen'shealthandFemTechmarketinJapanCHAPTER

01OverviewForecastofthetotalfemalepopulationinJapanfrom2023to2120(inmillions)ProjectionoftotalfemalepopulationJapan2023-21207063.9563.6763.3863.0862.7862.4662.1461.8158.12605040302010053.8849.644.940.2736.2232.3828.7927.1525.642120202320242025202620272028202920302040205020602070208020902100211021154Description:AsofNovember2023,thetotalfemalepopulationinJapanwasestimatedtobearound63.95millionpeople.Withanestimated25.64millionwomenby2120,thedataindicatedadecreaseofabout40percent.

ReadmoreNote(s):Japan;2023to2120Source(s):MinistryofInternalAffairsandCommunications(Japan);StatisticsBureauofJapanJapan:Lifeexpectancyofwomenatbirthfrom2011to2021LifeexpectancyofwomeninJapan202110086.4186.8386.9987.2687.3287.4587.7187.5787.1486.61908070605040302010085.9201120122013201420152016201720182019202020215Description:In2021,thelifeexpectancyofwomenatbirthinJapanremainednearlyunchangedataround87.57years.Incomparisonto2020,thelifeexpectancydecreasednotsignificantlyby0.1years(-0.11percent).

ReadmoreNote(s):Japan;2011to2021;WomenonlySource(s):WorldBankEmploymentrateofwomeninJapanfrom2014to2023FemaleemploymentrateJapan2014-202354.0%53.0%53.6%53%52.2%52.2%51.8%52.0%51.0%50.0%49.0%48.0%47.0%51.3%49.8%48.9%201648%47.6%2014201520172018201920202021202220236Description:In2023,theemploymentrateforwomeninJapanstoodat53.6percent,upfromabout47.6percentin2014.Themaleemploymentratewas69.5percentin2023.IncreasingnumberofworkingwomenAsJapanisfacingseveredemographicchallenges,thegovernmenthastriedformanyyearstoincreasethenumberofwomenintheworkforce.In2013,PrimeMinisterShinzoAbedeclaredhiscommitmenttocreating"asocietyinwhichwomenshine",callingit"amatterofthegreatest[...]

ReadmoreNote(s):Japan;2014to2023;15yearsandolderSource(s):e-Stat(Japan);MinistryofInternalAffairsandCommunications(Japan)ProductionvalueofmenstrualproductsinJapanfrom2013to2022(inbillionJapaneseyen)ProductionvalueofperiodproductsJapan2013-202280706070.7970.0469.2866.9862.1256.5153.6752.3751.5149.75040302010020132014201520162017201820192020202120227Description:In2022,theproductionvalueofmenstrualproductsinJapanstoodatapproximately69billionJapaneseyen,aslightincreasefromaround67billionyeninthepreviousyear.AccordingtotheMinistryofHealth,LabourandWelfareinJapan,periodproductsinthiscategoryincludesanitarynapkins(pads)andtampons.ReadmoreNote(s):Japan;2013to2022Source(s):MHLW(Japan)NumberofgynecologistsworkingatmedicalfacilitiesinJapanfrom2000to2020(in1,000s)NumberofgynecologistsworkingatmedicalfacilitiesJapan2000-20201411.6811.591210811.3511.3311.0611.0311.0910.8710.6510.3910.076420200020022004200620082010201220142016201820208Description:In2020,approximately11.7thousandgynecologistswereworkingatmedicalfacilitiesinJapan.Thisfigureincreasedslightlycomparedtoaround11.3thousandgynecologistsinthepreviousyear.

ReadmoreNote(s):Japan;2000to2020Source(s):MHLW(Japan)CHAPTER

02FemTechmarketFemalecareandfemaletechnology(FemTech)marketsizeinJapanfrom2019to2021withaforecastfor2022(inbillionJapaneseyen)FemalecareandFemTechmarketsizeJapan2019-2021807070.1164.359.7157.4660504030201002019202020212022*10Description:ThefemalecareandFemTechmarketinJapangrewfromapproximately57.5billionJapaneseyenin2019toover64billionyenin2021.Moregrowthwasestimatedin2022.

ReadmoreNote(s):Japan;2019to2021;*Forecast.Thefemalecareandfemtechmarketreferstothemarketofthefollowingfivecategories:1)menstruationrelateditems/services2)sterility/pregnancy/postpartumcareitems/services3)menopausecare[...]

ReadmoreSource(s):YanoResearchAwarenessleveloftheterm"FemTech"amongwomeninJapanasofMarch2023Awarenessleveloftheword"FemTech"amongwomenJapan202390%80%70%60%50%40%30%20%10%78.3%13.1%5.5%3.1%0%IhaveusedtheservicesandproductsbeforeIknowthetermandIknowthemeaningIknowthetermbutIdidnotknowthe

Idonotnowthetermormeaningmeaning11Description:AccordingtoasurveyconductedinJapanin2023,about78percentoffemalerespondentsinJapandidnotknowtheterm"FemTech",whichstandsforfemaletechnology.Onlyaround5.5percentofthesurveyedwomenwereawareofthemeaningoftheword.ReadmoreNote(s):Japan;March27to28,2023;954respondents;16-59years;femalerespondentsSource(s):NipponInformationIncorporatedIntentiontouseFemTechservicesorproductsamongwomeninJapanasofMarch2023IntentionofwomentouseFemTechproductsJapan202360%50%40%30%20%51.2%24.8%11.5%8.4%10%0%4.1%IwouldliketouseitIwouldratherliketouseitNeitherIwouldrathernotuseitIdonotwanttouseit12Description:AccordingtoasurveyconductedinJapanin2023,themajorityofwomenrespondedthattheydidnotwanttouseFemTechproducts,reachingashareofalmost25percent.Incontrast,onlyaroundfourpercentstatedthattheywouldliketouseFemTechproducts.ReadmoreNote(s):Japan;March27to28,2023;954respondents;16-59years;femalerespondentsSource(s):NipponInformationIncorporatedShareofwomenwhohaveusedFemTechservicesorproductsbeforeinJapanasofMarch2023,byageShareofwomenwhohaveusedFemTechservicesorproductsJapan2023,byageShareofrespondents2.0%

2.5%0.0%0.5%1.0%1.5%3.0%3.5%4.0%4.5%5.0%10to19yearsold4.6%20to29yearsold30to39yearsold40to49yearsold50to59yearsold4.2%3.6%2.5%1%13Description:AccordingtoasurveyconductedinJapanin2023,about4.6percentoffemalerespondentsbetweentheageof10and19yearssaidthattheyhaveusedFemTechproductsofservicesbefore,makingupthelargestagegroupwiththatexperience.Thesharewaslowestamong50to59-year-oldwomen,amountingtoonlyonepercent.ReadmoreNote(s):Japan;March27to28,2023;954*;16-59years;femalerespondents;*Respondentsbyage:10to19yearsold:n=17420to29yearsold:n=19030to39yearsold:n=19640to49yearsold:n=19750to59yearsold:n=197

ReadmoreSource(s):NipponInformationIncorporatedMostcommonFemTechproductsandservicesthatfemalerespondentswanttouseinJapanasofMarch2023MostcommonlydemandedFemTechproductsandservicesamongwomenJapan2023Shareofrespondents10%0%5%15%20%25%30%30.2%35%Delicatezonecare(oils,creams,etc.)DelicatezonededicatedsoapAbsorbentnapkins28.2%25.5%25.5%SupplementsAbsorbentpads24.8%PelvicfloormuscletrainingandpelviccaregoodsTraditionalChinesemedicineHerbalandaromaoils18.8%16.8%16.8%Hormonetesting15.4%Vaginalexercisegoods12.1%Heatingpads6%4.7%Nothinginparticular14Description:AccordingtoasurveyconductedinJapanin2023,approximately30.2percentofwomenrespondedthattheywantedtouseproductsfordelicatezonecare,suchasoilsorcreams,while28.2percentreportedwantingtousedelicatezonededicatedsoapforintimatewash.Incontrast,only4.7ofwomendidnotuseanyparticularFemTechproductsorservices.ReadmoreNote(s):Japan;March27to28,2023;149respondents;16-59years;femalerespondentsSource(s):NipponInformationIncorporatedMostcommonFemTechmenstrualcycle-relatedproductsandservicesthatwomenwanttouseinJapanasofMarch2023MostcommonlydemandedFemTechcycle-relatedproductsandservicesJapan2023Shareofrespondents0%5%10%15%20%25%30%35%40%High-qualitysanitarypads(organiccotton,etc.)*High-qualitypantyliners(organiccotton,etc.)*Menstrualcyclemanagementapp*Obtainingaprescriptionatclinic*36.9%32.2%28.9%20.1%Obtaininganonlineprescription*17.4%15.4%14.8%14.8%Menopausalcaresupplies****Clothpads*Pelvicbelt**Menstrualcup*11.4%10.1%9.4%8.1%7.4%Morningsicknesscare(smartbands,etc.toalleviatemorningsickness)**Hormonereplacementtherapy(HRT)forwomen****Stretchmarkscare(oils,backsupport,etc.)**Fertilitysupportappandservices***15Description:AccordingtoasurveyconductedinJapanin2023,themajorityofwomenrespondedthattheypreferredtousehigh-qualitysanitarypads,reachingashareofalmost37percent.Onlytwopercent,ontheotherhand,utilizedfertilitytesting.Productsandservicesassociatedwithmenstruationandthemenstrualcycletendedtobefavored.ReadmoreNote(s):Japan;March27to28,2023;149respondents;16-59years;femalerespondents;*Answersarerelatedtomenstruationandmenstrualcycle;**answersarerelatedtopregnancyorpost-partumperiods;***answersarerelatedto[...]

ReadmoreSource(s):NipponInformationIncorporatedMostcommonreasonstonotuseFemTechproductsamongfemalerespondentsinJapanasofMarch2023MostcommonreasonstonotuseFemTechproductsamongwomenJapan2023Shareofrespondents10%0%5%15%20%25%30%UnsureofwhattodoNotinterested26.7%22.5%Don'tknowwhattolookforSeemsexpensive19.3%14.9%Troublesome9.9%Vagueanxiety8%DoubtfulabouteffectivenessorfeelsquestionableConcernedabouttheeffectsofmedicationDon'tknowwhotoconsultNotime5.5%5.5%4.2%4.1%ConcernsaboutcompromisinghealthOther2%2.7%Nothinginparticular24.6%16Description:AccordingtoasurveyconductedinJapanin2023,approximately26.7percentofwomenrespondedthattheydidnotuseFemTechproductsduetotheirlackofknowledgeregardingtheirusage,whilearound22.5percentofwomenhighlightedbeingnotinterestedinthesetypesofproducts.Notably,24.6percentoftherespondentsdidnotgiveanyspecificrationalefornotusingFemTechproducts.ReadmoreNote(s):Japan;March27to28,2023;805respondents;16-59years;femalerespondentsSource(s):NipponInformationIncorporatedCHAPTER

03MenstruationStatusofmenstruationamongwomeninJapanasofMarch2022StatusofmenstruationamongwomenJapan2022Shareofrespondents0%5%10%15%20%25%IrregularmenstruationMenstrualcyclelongerthan39daysMenstrualcycleshorterthan24days21.8%14.1%12.4%18Description:AccordingtoasurveypublishedinMarch2022,21.8percentoffemaleJapaneserespondentssharedthattheyhaveirregularmenstruation.Thesecondcommonstatuswasthecyclebeinglongerthan39days.

ReadmoreNote(s):Japan;March3to6,2022;3,000respondents;18-49years;amongrespondentswhofindirregularitiesinmenstrualcycleSource(s):MHLW(Japan)LevelofdifficultywithmenstrualpaininJapanasofMarch2022LevelofdifficultywithmenstrualpainJapan2022Shareofrespondents0%10%20%30%40%50%60%70%LowdifficultyMediumdifficultyHighdifficulty62.5%37.2%0.3%19Description:AccordingtoasurveypublishedinJapaninMarch2022,62.5percentofrespondentssharedthattheyfeellowmenstrualpain.37.2percentoftherespondentssaidthattheyhadmediumdifficulty.ReadmoreNote(s):Japan;March2to6,2022;3,000respondents;18-49years;amongrespondentswhoexperiencemenstrualpainSource(s):MHLW(Japan)MostcommonsymptomsofpremenstrualsyndromeandpremenstrualmooddisturbancedisorderinJapanasofMarch2022MostcommonsymptomsofPMSandPMDDJapan2022Shareofrespondents0%10%20%30%40%50%60%TiredeasilyandlackofenergyEmotionalinstabilityPhysicalsymptomssuchasbreastpainortension,jointormusclepain,headache,swelling,orweightgain57.1%54%53.1%50.7%IncreasedappetiteorcravingsforcertainfoodsDeclineinconcentration44.1%Irritability,anger,andincreasedinterpersonalconflictHypersomniaorinsomnia43.6%42.8%Feelingdepressed,hopeless,andcriticalofoneselfFeelinganxious,nervous,oragitated36.9%36.9%Decreasedinterestinwork,school,friendships,andhobbiesFeelingoverwhelmedoroutofcontrol27.3%26.6%20Description:AccordingtoasurveypublishedinJapaninMarch2022,around57.1percentofrespondentssharedthattheytireeasilyorlackenergybeforetheirmenstruationinJapan.Additionally,about54percentoftherespondentssaidthattheyexperiencedemotionalinstability.ReadmoreNote(s):Japan;March2to6,2022;3,000respondents;18-49years;amongrespondentswhoexperiencePMSorPMDDSource(s):MHLW(Japan)ReasonsfornotseeingadoctoraboutmenstruationinJapanasofMarch2022ReasonsfornotseeingadoctoraboutmenstruationJapan2022Shareofrespondents0%10%20%30%40%50%60%NotcriticalenoughNotenoughtime52%19%Notenoughmoney14.4%11.9%10.4%9.2%DuetoCOVID-19DuetoembarrassmentDifficulttotaketimeofffromworkDifficulttotaketransportationDuetoconcernaboutothers5.4%5.3%NotsureofwhichmedicaldepartmentDonotwantguardiansorpeopleIlivewithtoknowGuardiansorpeopleIliveareagainsttreatmentOther3.5%3.3%1.2%3.1%Noreason19.3%21Description:AccordingtoasurveypublishedinJapaninMarch2022,52percentofrespondentssharedthattheydidnotthinktheirmenstruationstatuswascriticalenoughtoseeadoctorinJapan.Thesecondcommonreasonwasthattheydidnothavetimetogotoamedicalfacility.ReadmoreNote(s):Japan;March2to6,2022;606respondents;18-49years;amongrespondentswhofindirregularitiesinmenstrualcycle,multipleanswerspossibleSource(s):MHLW(Japan)FrequencyofusingtamponsamongpeoplewhomenstruateinJapanasofMarch2022FrequencyofusingtamponsamongpeoplewhomenstruateJapan202290%80%70%60%50%40%30%20%10%79.6%9.6%6.1%2.8%1.9%0%Everyday(7daysaweek)Almosteveryday(5-6daysaweek)Everyotherday(3-4daysa

Occasionally(1-2daysaweek)week)Never22Description:AccordingtoasurveypublishedinJapaninMarch2022,around79.6percentoftherespondentssharedthattheyneverusetamponsduringtheirmenstruation.Onlyabout2.8percentoftherespondentssaidthattheyuseditdailyduringtheirmenstruation.ReadmoreNote(s):Japan;March2to6,2022;3,000respondents;18-49years;amongrespondentswhomenstruateSource(s):MHLW(Japan)FrequencyofusingamenstrualcupamongpeoplewhomenstruateinJapanasofMarch2022FrequencyofusingamenstrualcupamongpeoplewhomenstruateJapan2022120%100%80%60%40%20%96.7%1%0.7%1.1%0.5%0%Everyday(7daysaweek)Almosteveryday(5-6daysaweek)Everyotherday(3-4daysa

Occasionally(1-2daysaweek)week)Never23Description:AccordingtoasurveypublishedinJapaninMarch2022,around96.7percentoftherespondentssharedthattheyneverusedamenstrualcupduringtheirmenstruation.Onlyaboutonepercentoftherespondentssaidthattheyuseditdaily.

ReadmoreNote(s):Japan;March2to6,2022;3,000respondents;18-49years;amongrespondentswhomenstruateSource(s):MHLW(Japan)FrequencyofusingsanitarypapernapkinsamongpeoplewhomenstruateinJapanasofMarch2022FrequencyofusingsanitarypapernapkinsamongpeoplewhomenstruateJapan202280%70%60%50%40%30%20%10%0%75.5%15%4.6%3.4%1.5%Everyday(7daysaweek)Almosteveryday(5-6daysaweek)Everyotherday(3-4daysa

Occasionally(1-2daysaweek)week)Never24/statistics/1449304/japan-frequency-of-using-sanitary-paper-napkinsAccordingtoasurveypublishedinJapaninMarch2022,around75.5percentoftherespondentssharedthattheyusedsanitarypapernapkinsondailyduringtheirmenstruation.About3.4percentoftherespondentssaidthattheyneveruseit.

ReadmoreNote(s):Japan;March2to6,2022;3,000respondents;18-49years;amongrespondentswhomenstruateSource(s):MHLW(Japan)CHAPTER

04PregnancyandfertilitytreatmentJapan:Fertilityratefrom2011to2021FertilityrateinJapan2011-20211.61.451.441.431.431.421.421.411.391.361.41.21.00.80.60.40.20.01.331.32011201220132014201520162017201820192020202126Description:In2021,thetotalfertilityrateinJapandecreasedby0.03childrenperwoman(-2.26percent)since2020.Therefore,2021marksthelowestfertilityrateduringtheobservedperiod.

ReadmoreNote(s):Japan;2011to2021Source(s):WorldBankMeanageofchildbearinginJapanfrom1950to2021withaforecastuntil2030MeanageofchildbearingJapan1950-203032.531.530.529.528.527.526.527Description:ThemeanageofchildbearinginJapanwasestimatedataround31.4yearsin2021,slightlydownfromthepreviousyear.WithintheAsianregion,Japanshowedoneofthehighestmeanageofchildbearing.

ReadmoreNote(s):Japan;1950to2021;*Projections.ReadmoreSource(s):UNDESANumberoflivebirthsinJapanfrom2013to2022NumberoflivebirthsJapan2013-20221,200,0001,029,8171,003,6091,005,721977,2421,000,000800,000600,000400,000200,0000946,146918,400865,239840,835811,622770,759201320142015201620172018201920202021202228Description:In2022,approximately770.8thousandlivebirthswererecordedinJapan,continuingthedownwardtrendofthelastdecade.Inthesameyear,thenumberofdeathsofnewbornsamountedto609.

ReadmoreNote(s):Japan;2013to2022Source(s):MHLW(Japan)Numberoflivebirthsresultingfromassistedreproductivetechnology(ART)inJapanfrom1985to2021,byproceduretypeNumberofARTlivebirths1985-2021Japan,bytypeInvitrofertilization(IVF)*Intracytoplasmicsperminjection(ICSI)**Frozenembryotransfer(FET)80,00070,00060,00050,00040,00030,00020,00010,000029Description:In2021,around69.78thousandlivebirthsresultingfromassistedreproductivetechnology(ART)wererecordedinJapan,ofwhicharound64.68thousandwerefromfrozenembryotransfer(FET).IntheFETprocedure,embryosthatwerecreatedinapreviousinvitrofertilization(IVF)cycleareusedusually.ReadmoreNote(s):Japan;1985to2021;*Includinggameteintrafallopiantransfer(GIFT)andothers.**Includingsplit.ReadmoreSource(s):JSOGNumberofcyclesofassistedreproductivetechnology(ART)treatmentsperformedinJapanin2021,byageofpatientNumberofperformedcyclesofARTtreatmentsJapan2021,byage45,00040,00035,00030,00025,00020,00015,00010,0005,000030Description:In2021,patientsinJapanaged40yearsoldunderwentabout39.38thousandcyclesofassistedreproductivetechnology(ART)treatments.Thehighestnumbercouldbeseenamongpatientsagedbetween39and41yearsold,witharound39.62thousandcycles.ReadmoreNote(s):Japan;2021Source(s):JSOGEstimatednumberofpatientsperdayreceivingtreatmentsforhypertensivedisordersofpregnancyinJapanfrom1996to2020(in1,000s)NumberofhypertensivedisordersofpregnancyJapan1996-20202.01.81.81.61.41.21.00.80.60.40.20.01.41.10.80.70.70.70.70.619961999200220052008201120142017202031Description:InOctober2020,anestimatednumberofaround800patientsinadayweretreatedforhypertensivedisordersduringpregnancy.Thenumberwashighestin1996atabout1.8thousandtreatedpatientsperday.

ReadmoreNote(s):Japan;1996to2020;asofonedayinOctoberofeachyearSource(s):MHLW(Japan)EstimatednumberofpatientsperdayreceivingtreatmentsforpregnancywithabortiveoutcomeinJapanfrom1996to2020,bytype(in1,000s)NumberofpregnancieswithabortiveoutcomeJapan1996-2020,bytype4.03.53.53.02.52.01.51.00.50.03.23.22.82.52.32.32.21.719961999200220052008201120142017202032Description:InOctober2020,anestimated1.7thousandpatientsadayweretreatedforpregnancieswithabortiveoutcomeinJapan.Thisincludedthenumberofpatientswhohadanectopicpregnancy,hydatidiformmole,spontaneousandmedicalabortion,amongothers.ReadmoreNote(s):Japan;1996to2020;asofonedayinOctoberofeachyearSource(s):MHLW(Japan)CHAPTER

05MenopauseShareofwomenwhohaveexperiencedmenopausalsymptomsinJapanasofSeptember2023,byageShareofwomenwhohaveexperiencedmenopausalsymptomsJapan2023,byage80%70%60%50%40%30%73.6%65.8%44.9%20.4%20%8.9%10%0%4%2.4%20to24years25to29years30to34years35to39years40to44years45to49years50yearsandolder34Description:AccordingtoanonlinesurveyconductedinJapanin2023,73.6percentofrespondentsover50yearsoldansweredthattheyhaveexperiencedsymptomsofmenopause.Forrespondentsbetween45and49yearsold,65.8percentstatedtheyhaveexperiencedit.ReadmoreNote(s):Japan;September15to22,2023;4,978respondents;10yearsandolder;onlyfemalerespondents;onlywomenwhoansweredthattheydidexperiencesymptomsSource(s):FujiPharma;MTI;PRTimesMostcommonmentalsymptomsofmenopauseinJapanasofSeptember2023MostcommonmentalsymptomsofmenopauseJapan2023Shareofrespondents30%0%10%20%40%50%60%70%IrritabilityFatigue63%60.5%Anxiety43%42.4%42.2%DecreasedmotivationInsomnia35Description:AccordingtoanonlinesurveyconductedinJapanin2023,themostcommonmentalsymptomofmenopause,asreportedbyrespondents,isirritability,with63percentofrespondentsnamingthatsymptom.Followingclosely,fatigueemergedasthesecondmostcommonsymptom,with60.5percentofrespondentslistingit.ReadmoreNote(s):Japan;September15to22,2023;2,003respondents;10yearsandolder;onlywomenwhoansweredtheyhaveexperiencedmenopausalsymptomswereaskedSource(s):FujiPharma;MTI;PRTimesMostcommonphysicalsymptomsofmenopauseinJapanasofSeptember2023MostcommonphysicalsymptomsofmenopauseJapan2023Shareofrespondents20%

30%0%10%40%50%60%SweatingBodypain*56.4%53%MenstrualirregularitiesStiffshoulders48.7%45.7%Hotflashes43.9%36Description:AccordingtoanonlinesurveyconductedinJapanin2023,themostcommonphysicalsymptomofmenopause,asreportedbyrespondents,issweating,with56.4percentnamingit.Followingclosely,bodypain,suchasheadache,backpain,jointpainandbackache,emergedasthesecondmostcommonsymptom,with53percentofrespondentslistingit.ReadmoreNote(s):Japan;September15to22,2023;2,018respondents;10yearsandolder;onlywomenwhoansweredtheyhaveexperiencedmenopausalsymptomswereaskedSource(s):FujiPharma;MTI;PRTimesLevelofdiscomfortduetomenopauseinJapanasofAugust2023LevelofdiscomfortduetomenopauseJapan2023ShareofrespondentsSeriousenoughtointerferewithdailylife0%

20%SeriousNotveryseriousHardlyserious60%

80%40%100%120%IamawareofmenopauseanddiagnosedbyadoctorIamnotdiagnosedbyadoctor,butIamawareofmenopauseIthinkitmaybemenopause37Description:AccordingtoanonlinesurveyconductedamongwomeninJapanin2023,over10percentofrespondentsdiagnosedwithmenopausebyadoctorreportedthatthediscomfortcausedbymenopausesignificantlyinterfereswithdailylife,andover30percentstateditisserious.Amongthoseawareofmenopausewithoutadoctor'sdiagnosis,4.5percentreportedsignificantinterferencewithdailylifeduetodiscomfort,whileover20percentstateditisserious.

ReadmoreNote(s):Japan;August24to25,2023;600respondents;30-69years;onlywomenwereaskedSource(s):HakuhodoMostcommonwaysofdealingwithmenopausalsymptomsinJapanasofSeptember2023MostcommonwaysofdealingwithmenopausalsymptomsJapan2023Shareofrespondents0%

10%20%30%40%50%60%70%80%Supplements,traditionalChinesemedicine,andover-the-countermedicationsImprovingdietaryhabits(payingattentiontonutritionalbalance)Stressrelief(reduction)66.7%35.2%32.6%Developinganexerciseroutine30.8%Seekingsupportfromfamilyandthosearoundyou27.8%38Description:AccordingtoanonlinesurveyconductedinJapanin2023,otherthanmedicaltreatments,themostcommonwaytodealwithmenopausalsymptoms,asreportedbyrespondents,istotakesupplements,traditionalChinesemedicineandover-the-countermedications,with66.7percentnamingit.Improvingdietaryhabitsemergedasthesecondmostcommonmeasure,with35.2percentofrespondentslistingit.ReadmoreNote(s):Japan;September15to22,2023;281respondents;10yearsandolder;onlywomenwhoansweredtheyhaveexperiencedmenopausalsymptomsandtookmeasureswereaskedSource(s):FujiPharma;MTI;PRTimesShareofwomenwhohaveconsultedamedicalinstitutionaboutmenopausalsymptomsinJapanasofSeptember2023ShareofwomenconsultingamedicalinstitutionformenopausalsymptomsJapan2023Ihave31.9%Ihavenot68.1%39Description:AccordingtoanonlinesurveyconductedinJapanin2023,68.1percentofrespondentsansweredtheyhaveneverconsultedamedicalinstitutionabouttheirmenopausalsymptoms.Theshareofrespondentswhohaveconsultedamedicalinstitutionwasmuchsmaller.ReadmoreNote(s):Japan;September14to18,2023;335respondents;40yearsandolder;onlywomenwhohaveexperiencedmenopausalsymptomswereaskedSource(s):PharmaX;PRTimesMostcommonchangesoffeelingsafterbecomingawareofmenopauseinJapanasofAugust2023MostcommonchangesoffeelingsafterbecomingawareofmenopauseJapan2023Shareofrespondents0%

10%20%30%40%50%60%70%80%71.6%68.4%66.4%IaccepteditasanunavoidableaspectofagingIstartedtobelievethatthesymptomswillimproveeventuallyIfeltrelievedafterunderstandingthecauseofthesymptomsIbecamemoremindfulofmyownhealthcondition65.8%64.7%IbecamemorerelaxedknowingthatothersaroundmeareexperiencingsimilarsymptomsIbecameabletotalkaboutittopeoplearoundmeIbecameabletocopewithandseektreatmentIfeltnegativeuponrealizingitwasmenopauseIimprovedrelationshipswithpeoplearoundme53.6%49.2%44.8%32.8%40Description:AccordingtoanonlinesurveyconductedinJapanin2023,aschangesoffeelingsafterbecomingawareofmenopause,71.6percentofrespondentscitedthattheyaccepteditasanunavoidableaspectofaging.Followingclosely,68.4percentofre